NK
Nageswari Korsipati
About Nageswari Korsipati
Data last updated:
Nageswari Korsipati was a Director at Myhaz Pharma Private Limited (2017–2020) and Director at Nefro Life Sciences Private Limited (from 2018). The companies operate in Business Services.
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Myhaz Pharma Private Limited U74999TG2017PTC120761 | Director | 22 Nov 2017 | 2017 | ₹31.8 Lakh (FY 2025) | Active |
| Nefro Life Sciences Private Limited U74999KA2018PTC118576 | Director | 16 Nov 2018 | 2018 | Strike Off |
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nageswari Korsipati
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nageswari Korsipati
Nageswari Korsipati was first appointed on 22 Nov 2017 as Director at Myhaz Pharma Private Limited. The most recent appointment on record is 16 Nov 2018 at Nefro Life Sciences Private Limited.
Nageswari Korsipati held 2 earlier board appointments: Myhaz Pharma Private Limited (Director, 22 Nov 2017 to 10 Mar 2020); Nefro Life Sciences Private Limited (Director, from 16 Nov 2018).